SCHEMBL19389828

SCHEMBL19389828

C=C(C)c1cccc(Nc2c(C#N)cnc3cc(O[C@@H]4CCOC4)c(NC(=O)/C=C/CN(C)C)cc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.63
▸ ERBB2 P04626 15/20 0.63
▸ CIT O14578 2/20 0.55
▸ GAK O14976 2/20 0.55
▸ STK10 O94804 2/20 0.55
▸ ABL1 P00519 2/20 0.55
▸ LCK P06239 2/20 0.55
▸ LYN P07948 2/20 0.55
▸ MET P08581 2/20 0.55
▸ HCK P08631 2/20 0.55
▸ SRC P12931 2/20 0.55
▸ PHKG2 P15735 2/20 0.55
▸ AXL P30530 2/20 0.55
▸ FLT3 P36888 2/20 0.55
▸ TXK P42681 2/20 0.55
▸ FRK P42685 2/20 0.55
▸ CSNK1E P49674 2/20 0.55
▸ BLK P51451 2/20 0.55
▸ ERBB4 Q15303 2/20 0.55
▸ PHKG1 Q16816 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18933433 1.00 EGFR (0.63) EGFRERBB2CITGAKSTK10
SCHEMBL18933494 0.94 EGFR (0.63) EGFRERBB2CITGAKSTK10
SCHEMBL18933591 0.94 EGFR (0.55) EGFRERBB2
SCHEMBL19389770 0.92 EGFR (0.56) EGFRERBB2
SCHEMBL18933479 0.92 EGFR (0.55) EGFRERBB2
SCHEMBL14855250 0.91 EGFR (0.67) EGFRERBB2
SCHEMBL21569034 0.91 EGFR (0.67) EGFRERBB2
SCHEMBL18933474 0.91 EGFR (0.64) EGFRERBB2CITGAKSTK10
SCHEMBL18949445 0.91 EGFR (0.64) EGFRERBB2CITGAKSTK10
SCHEMBL19389827 0.91 EGFR (0.64) EGFRERBB2CITGAKSTK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3222620-B1 CYANOQUINOLINE DERIVATIVES TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD (CN) 2019-11-20 — — EP disclosed
EP-3222620-A1 CYANOQUINOLINE DERIVATIVES TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD. (CN) 2017-09-27 — — EP disclosed
Send feedback